MyBlueDotsMeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR MyBlueDots7 days ago01 mins ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)– #AMR–These new members bring decades of experience in medicine, industry, and healthcare policy, strengthening MeMed’s work in host-response technologies. Post navigation Previous: Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025Next: Syringe exchange fears hobble fight against West Virginia HIV outbreak
Powered by machine learning, a new blood test can enable early detection of multiple cancers MyBlueDots2 days ago 0